Reliance Life Sciences gets DCGI approval for COVID vaccine trial Ruchika Sharma4 Sept 2021 1:36 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct...
CDSCO asks drugmakers to market Tolperisone, Paracetamol FDC solely for revised indication Medical Dialogues Team2 Sept 2021 4:45 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has directed all State and Union Territory (UT) drug controllers to instruct all...
DCGI nod to phase 2, 3 trials of Biological E Corbevax in children Medical Dialogues Team2 Sept 2021 12:31 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3...
Gennova gets DCGI nod for Phase 2, 3 trials of its mRNA COVID vaccine Ruchika Sharma25 Aug 2021 12:28 PM ISTNew Delhi: India's first mRNA-based Covid-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for phase 2/3...
Covid-19: Adolescents likely to get Zydus Cadila DNA vaccine after 4 weeks Ruchika Sharma24 Aug 2021 1:36 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Friday approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12...
DCGI likely to approve Covaxin for kids prior trial period MD Bureau23 Aug 2021 11:00 AM ISTBengaluru: The Central government and the Drugs Controller General of India (DCGI) may give approval to the Covaxin vaccines for children soon for...
CDSCO extends deadline to submit details of 19 FDC drugs Medical Dialogues Team21 Aug 2021 7:00 PM ISTNew Delhi: Following several requests for an extension of the deadline for submitting information on the rationality, safety, and efficacy of pre-1988...
First: Zydus Cadila needle-free COVID vaccine gets DCGI nod, PM Modi says momentous feat Medical Dialogues Team21 Aug 2021 4:03 PM ISTAhmedabad: In a significant development, Ahmedabad-based pharmaceutical firm Zydus Cadila has received Emergency Use Authorisation (EUA) from the Drug...
Enzene Biosciences Romiplostim gets DCGI marketing authorization Ruchika Sharma20 Aug 2021 4:33 PM ISTRomiplostim, a therapeutic fusion protein, acts as a thrombopoieses stimulating factor, thereby restoring platelet levels and ameliorating the...
Bharat Biotech study on Covaxin, nasal COVID jab cocktail gets DCGI nod: Report Medical Dialogues Team13 Aug 2021 3:49 PM ISTHyderabad: In a significant advancement in Covid 19 vaccine development, Bharat Biotech has got approval from the Drug Controller General of India...
iSERA Biological begins COVID drug human trials Ruchika Sharma12 Aug 2021 11:00 AM ISTThe results so far have been encouraging, Pratap Deshmukh said, adding the company will be able to deliver the drug at a tenth of the cost charged by...
Study on mixing of Covaxin, Covishield doses get DCGI okay Ruchika Sharma11 Aug 2021 4:04 PM ISTNew Delhi: India's drug regulator has given approval for a study to be conducted by the Christian Medical College (CMC), Vellore on mixing of COVID-19...
